Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Older women at highest risk for hip fractures, least likely to get bone density screening

09.02.2006


A new study by Medical College of Wisconsin researchers has found that women who most need bone density testing to determine if they have osteoporosis are the least likely to get it. They are older women who are among the highest risk groups and who suffer most if they break a bone. The study is published in the March issue of the Journal of the American Geriatric Society.

"Over half of hip fracture patients never regain their prior level of functioning and 20 percent of them require nursing home care," according to Joan M. Neuner, M.D., M.P.H., lead author and assistant professor of medicine at the Medical College. Dr. Neuner is on the staff at Froedtert Hospital. "Women are very interested in preventing bone fractures. In an earlier study, 80 percent of women said they would "rather die" than enter a nursing home with a hip fracture."

Osteoporosis, in which the body breaks down bone faster than it is replaced, leading to lace-like, fragile bones, is a significant risk for older women. Nineteen percent of women in the age 65-74 group have it, 32.5 percent of women age 75-84, and over half of women over age 85.



The research team did a statistical analysis to see if older women are more or less likely to have the bone density test that would tell them their bone status. The retrospective study – one in which they looked at existing data to gain a new understanding – looked at the Medicare records of nearly 44,000 women from age 65 to 90 to see how many of them had a bone density test from 1999 (the first year Medicare paid for it) to 2001. They looked at the association between frequency of testing and the age of the women, controlling for factors such as socioeconomic class, race and other diseases they may have had.

"Since osteoporosis can be helped with appropriate therapy, it is especially important for older women to find out whether or not they need the therapy. Treatment with hormones or bone-building drugs can slow the process, rebuild some bone and reduce the risk of fracture by one-third," Dr. Neuner says.

The best scenario would be the oldest women being the most frequent subjects of bone density screenings. That did not prove to be the case. In fact, the research team found just the opposite. The older the age group, the fewer women had bone density tests.

The numbers were not heartening: 27 percent of women in the youngest age group, 65-70, had the test. At age 71-75, only 25.6 percent had it and; after age 75, the number fell to less than 10 percent.

Since this was a statistical study and no women were interviewed, the researchers could not determine the reason why older women failed to get the test. But they offer some possible reasons:

  • Physicians not realizing the importance of bone density testing, or not being aware of how great women’s life expectancy is – at age 80 most women can expect to live another nine years
  • Physicians not being aware that osteoporosis treatment can reduce the risk of fracture in just three years
  • Women having side effects from the treatment drugs or just not liking to take prescription medications
  • Women not realizing that they are at risk, or mistakenly believing that osteoporosis is natural part of aging

The study points out the need for greater patient and physician education to convince women to get the testing they need, especially as they grow older and to determine if osteoporosis therapy would benefit them.

"Preventive care for older patients must be performed with an understanding of their life expectancy and values," Dr. Neuner says. "Osteoporosis screening may offer important opportunities to improve quality of life for many older patients."

Toranj Marphetia | EurekAlert!
Further information:
http://www.mcw.edu

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>